Medivolve Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CAD 37.18 million compared to CAD 86.82 million a year ago. Net loss was CAD 18.37 million compared to CAD 6.61 million a year ago.

Basic loss per share from continuing operations was CAD 0.68 compared to CAD 0.34 a year ago.